Research News

The GW School of Medicine and Health Sciences is one of only two sites chosen for the first clinical trial of a HIV vaccine candidate.

Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.

Rong Li, PhD, will serve as chair of the Department of Biochemistry and Molecular Medicine at the GW School of Medicine and Health Sciences. 

The GW Postdoc Association hosted Postdoc Appreciation Day on Sept. 21 as part of the National Postdoc Association Postdoc Appreciation Week from Sept. 17–21. 

Norman Lee, PhD, is investigating the mechanism behind dysregulation splicing factor expression.

Paul Brindley, PhD, has received more than $1.7 million from the National Cancer Institute at the National Institutes of Health to investigate the cellular and molecular links between liver fluke infection and bile duct cancer.

The GW School of Medicine and Health Sciences is one of 12 top medical research centers to collaborate with the Scleroderma Research Foundation to launch CONQUER: the first-ever national, longitudinal patient registry for those suffering from scleroderma.

The GW Cancer Center is pleased to announce that Katherine Chiappinelli, PhD, was awarded a prestigious grant from The G. Harold and Leila Y. Mathers Foundation.

Transgender individuals may be at higher risk for heart disease, according to a review article published by Michael S. Irwig, MD, associate professor of medicine, in Reviews in Endocrine and Metabolic Disorders.

Robert H. Miller, PhD, a neuroscientist, researcher, and administrator in the GW School of Medicine and Health Sciences, has been named the university’s new vice president for research.